Cargando…
Clinical guidelines—the challenges and opportunities: What we have learned from the case of misoprostol for postpartum hemorrhage
OBJECTIVE: To establish whether national guidelines for postpartum hemorrhage (PPH) reflect new scientific evidence on misoprostol, and determine the challenges faced in their implementation. METHODS: A web‐based survey was sent by email to 130 national societies of obstetrics and gynecology (FIGO M...
Autores principales: | Morris, Jessica L., Khatun, Samia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379921/ https://www.ncbi.nlm.nih.gov/pubmed/30387124 http://dx.doi.org/10.1002/ijgo.12704 |
Ejemplares similares
-
FIGO/ICM guidelines for preventing Rhesus disease: A call to action
por: Visser, Gerard H. A., et al.
Publicado: (2021) -
FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
por: Prat, Jaime
Publicado: (2015) -
FIGO staging of endometrial cancer: 2023
por: Berek, Jonathan S., et al.
Publicado: (2023) -
Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013) -
Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012)